Business Monitor ranks Costa Rica and Panama as top for Central Americas Pharma

Share Article

Business Monitor release new whitepaper on the investment opportunities within the Central American Pharmaceuticals sector, and the risks and rewards as well as trends and developments facing those looking to invest.

industry analysis, business forecasts, business monitor
Heavy reliance on imported medicine in the region provides revenue-generating opportunities for generic drugmakers from neighbouring Latin American countries and India.

Business Monitor has just released its latest analysis on the Central American Pharmaceuticals investment opportunities in their new whitepaper ‘Central America Investment Opportunities in Pharmaceuticals: Risk/Reward Analysis’. The whitepaper includes Business Monitor’s country comparative risks and rewards ratings tables for the pharmaceuticals industry in each country, headline expenditure projections and key trends and developments.

A snapshot of the whitepaper:

BMI View: The pharmaceutical market in Central America - consisting of the seven markets of Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Belize - is yet to fully develop its domestic manufacturing capabilities, and therefore depends on a large amount of pharmaceutical imports. Heavy reliance on imported medicine in the region provides revenue-generating opportunities for generic drugmakers from neighbouring Latin American countries and India. We highlight that Costa Rica and Panama are the premier countries in the region where foreign drugmakers can expand their presence…

In June 2013, Colombia-based pharmaceutical company Tecnoquímicas planned to buy a laboratory worth US$25mn in Guatemala. The company considers Central America a region with interesting opportunities, according to Emilio Sardi, the vice president of the company. Sardi added that given its knowledge in product handling and their marketing, the company can compete successfully in these regions. The move follows the company's acquisition of Wasser Hidraplus Chemical and the Baxter brand.

To read the rest of this brand new whitepaper and to gain access to even more of Business Monitor’s expert views and analysis, please click here or contact Sarah Sutcliffe at Press(at)businessmonitor(dot)com.

Business Monitor is a leading, independent provider of proprietary data, analysis, ratings, rankings and forecasts covering 195 countries and 24 industry sectors. It offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah Sutcliffe
@BusinessMonitor
since: 03/2009
Follow >
Business Monitor International
since: 01/2011
Like >
Follow us on
Visit website